NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

OBGYN & Reproduction Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Enzymology



Researchers provide details of new studies and findings in the area of enzymology



July 4th, 2005

New findings from Japan, Germany and the South Korea describe advances in enzymology.

Study 1: COX-2 may allow cancer cells to evade the immune system.

According to a study from Japan, "although there are several hypotheses explaining the mechanisms of immune-privileged status of malignant tumor, the exact pathway has yet to be explored. Cyclooxygenase (COX)-2 plays a vital role in prognosis of cancer patients in terms of contribution to neoangiogenesis and apoptosis inhibition; however, the impact of COX-2 in immunomodulation has not been reported."

"We have evaluated the expression of COX-2 and its impact on infiltration of...


Source: OBGYN & Reproduction Week (2005-07-04)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login